
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $572.1M | $731.2M | $792.5M | $846M | $862.6M | |
Revenue Growth (YoY) | 14.46% | 27.83% | 8.37% | 6.75% | 1.96% | |
Cost of Revenues | $428.5M | $551.9M | $608.9M | $656.5M | $738.3M | |
Gross Profit | $143.6M | $179.3M | $183.6M | $189.5M | $124.3M | |
Gross Profit Margin | 25.1% | 24.52% | 23.16% | 22.4% | 14.42% | |
R&D Expenses | $68.1M | $77.7M | $80.8M | $74.2M | $55M | |
Selling, General & Admin | $88.2M | $124.8M | $164.7M | $183.6M | $203.7M | |
Other Inc / (Exp) | -$21.5M | $239.3M | -$179.3M | -$55.7M | -$114.5M | |
Operating Expenses | $84.4M | $130M | $161.6M | $218.3M | $209.8M | |
Operating Income | $59.2M | $49.3M | $22M | -$28.8M | -$85.4M | |
Net Interest Expenses | $8.1M | $8.3M | $5.1M | $2.7M | $10M | |
EBT. Incl. Unusual Items | $29.5M | $280.4M | -$162.4M | -$87.3M | -$210M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $22.3M | $25.4M | $22.9M | $3.6M | $2.3M | |
Net Income to Company | $7.2M | $255M | -$185.2M | -$90.8M | -$212.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $7.2M | $255M | -$185.2M | -$90.8M | -$212.2M | |
Basic EPS (Cont. Ops) | $0.02 | $0.77 | -$0.52 | -$0.25 | -$0.60 | |
Diluted EPS (Cont. Ops) | $0.02 | $0.77 | -$0.52 | -$0.25 | -$0.60 | |
Weighted Average Basic Share | $307.5M | $332.8M | $353.3M | $353.8M | $354.6M | |
Weighted Average Diluted Share | $307.5M | $332.8M | $353.3M | $353.8M | $354.6M | |
EBITDA | $103.2M | $374.6M | -$60.8M | $26.1M | -$87.3M | |
EBIT | $39.2M | $291.3M | -$148.5M | -$74.5M | -$197.3M | |
Revenue (Reported) | $572.1M | $731.2M | $792.5M | $846M | $862.6M | |
Operating Income (Reported) | $59.2M | $49.3M | $22M | -$28.8M | -$85.4M | |
Operating Income (Adjusted) | $39.2M | $291.3M | -$148.5M | -$74.5M | -$197.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $160.4M | $184.8M | $229.4M | $226.7M | $210.4M | |
Revenue Growth (YoY) | 21.71% | 15.22% | 24.13% | -1.16% | -7.19% | |
Cost of Revenues | $123.4M | $148.5M | $172.2M | $189M | $181.8M | |
Gross Profit | $37M | $36.2M | $57.2M | $37.8M | $28.6M | |
Gross Profit Margin | 23.05% | 19.61% | 24.93% | 16.65% | 13.62% | |
R&D Expenses | $22.2M | $20.3M | $19.9M | $17.6M | $11.3M | |
Selling, General & Admin | $25.5M | $35.4M | $45.7M | $49.9M | $50.2M | |
Other Inc / (Exp) | $59.6M | -$73.9M | -$20.5M | -$7.9M | -$9.3M | |
Operating Expenses | $28.8M | $35.7M | $43.7M | $57.5M | $49.5M | |
Operating Income | $8.2M | $519.5K | $13.4M | -$19.8M | -$20.9M | |
Net Interest Expenses | $2.2M | $3.8M | -- | $1.4M | $1.3M | |
EBT. Incl. Unusual Items | $65.6M | -$77.1M | -$6.7M | -$29.1M | -$31.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.1M | $5.1M | $8.3M | -$6.6M | $1.8M | |
Net Income to Company | $63.5M | -$82.2M | -$14.9M | -$22.5M | -$33.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $63.5M | -$82.2M | -$14.9M | -$22.5M | -$33.2M | |
Basic EPS (Cont. Ops) | $0.19 | -$0.23 | -$0.04 | -$0.06 | -$0.09 | |
Diluted EPS (Cont. Ops) | $0.19 | -$0.23 | -$0.04 | -$0.07 | -$0.09 | |
Weighted Average Basic Share | $328.2M | $353.4M | $353.9M | $354.6M | $355.1M | |
Weighted Average Diluted Share | $328.2M | $353.4M | $353.9M | $354.6M | $355.1M | |
EBITDA | $68.4M | -$72.5M | -$4M | -$26.2M | -$28.9M | |
EBIT | $68.4M | -$72.5M | -$4M | -$26.2M | -$28.9M | |
Revenue (Reported) | $160.4M | $184.8M | $229.4M | $226.7M | $210.4M | |
Operating Income (Reported) | $8.2M | $519.5K | $13.4M | -$19.8M | -$20.9M | |
Operating Income (Adjusted) | $68.4M | -$72.5M | -$4M | -$26.2M | -$28.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $602.1M | $753.6M | $834.1M | $842.9M | $845.7M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $457.5M | $576M | $631M | $672.9M | $730.8M | |
Gross Profit | $144.6M | $177.6M | $203M | $170M | $114.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $73.7M | $76M | $80.2M | $71.9M | $48.8M | |
Selling, General & Admin | $94.8M | $134.2M | $174.1M | $187.8M | $203.9M | |
Other Inc / (Exp) | $32.8M | $108.9M | -$127.3M | -$42.9M | -$115.4M | |
Operating Expenses | $94.5M | $136.4M | $168.7M | $232.5M | $201.9M | |
Operating Income | $50.1M | $41.2M | $34.3M | -$62.5M | -$87.1M | |
Net Interest Expenses | $8.5M | $9.8M | $1.2M | $4.4M | $9.8M | |
EBT. Incl. Unusual Items | $74.4M | $140.3M | -$94.2M | -$109.8M | -$212.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $22.8M | $27.8M | $25.9M | -$11.3M | $10.2M | |
Net Income to Company | $51.8M | $109.3M | -$118M | -$98.4M | -$223M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $51.6M | $112.5M | -$120.1M | -$98.5M | -$222.6M | |
Basic EPS (Cont. Ops) | $0.15 | $0.36 | -$0.34 | -$0.28 | -$0.63 | |
Diluted EPS (Cont. Ops) | $0.15 | $0.36 | -$0.34 | -$0.28 | -$0.63 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $84.8M | $153.1M | -$82.2M | -$96.9M | -$200.1M | |
EBIT | $84.8M | $153.1M | -$82.2M | -$96.9M | -$200.1M | |
Revenue (Reported) | $602.1M | $753.6M | $834.1M | $842.9M | $845.7M | |
Operating Income (Reported) | $50.1M | $41.2M | $34.3M | -$62.5M | -$87.1M | |
Operating Income (Adjusted) | $84.8M | $153.1M | -$82.2M | -$96.9M | -$200.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $160.4M | $184.8M | $229.4M | $226.7M | $210.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $123.4M | $148.5M | $172.2M | $189M | $181.8M | |
Gross Profit | $37M | $36.2M | $57.2M | $37.8M | $28.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $22.2M | $20.3M | $19.9M | $17.6M | $11.3M | |
Selling, General & Admin | $25.5M | $35.4M | $45.7M | $49.9M | $50.2M | |
Other Inc / (Exp) | $59.6M | -$73.9M | -$20.5M | -$7.9M | -$9.3M | |
Operating Expenses | $28.8M | $35.7M | $43.7M | $57.5M | $49.5M | |
Operating Income | $8.2M | $519.5K | $13.4M | -$19.8M | -$20.9M | |
Net Interest Expenses | $2.2M | $3.8M | -- | $1.4M | $1.3M | |
EBT. Incl. Unusual Items | $65.6M | -$77.1M | -$6.7M | -$29.1M | -$31.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.1M | $5.1M | $8.3M | -$6.6M | $1.8M | |
Net Income to Company | $63.5M | -$82.2M | -$14.9M | -$22.5M | -$33.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $63.5M | -$82.2M | -$14.9M | -$22.5M | -$33.2M | |
Basic EPS (Cont. Ops) | $0.19 | -$0.23 | -$0.04 | -$0.06 | -$0.09 | |
Diluted EPS (Cont. Ops) | $0.19 | -$0.23 | -$0.04 | -$0.07 | -$0.09 | |
Weighted Average Basic Share | $328.2M | $353.4M | $353.9M | $354.6M | $355.1M | |
Weighted Average Diluted Share | $328.2M | $353.4M | $353.9M | $354.6M | $355.1M | |
EBITDA | $68.4M | -$72.5M | -$4M | -$26.2M | -$28.9M | |
EBIT | $68.4M | -$72.5M | -$4M | -$26.2M | -$28.9M | |
Revenue (Reported) | $160.4M | $184.8M | $229.4M | $226.7M | $210.4M | |
Operating Income (Reported) | $8.2M | $519.5K | $13.4M | -$19.8M | -$20.9M | |
Operating Income (Adjusted) | $68.4M | -$72.5M | -$4M | -$26.2M | -$28.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $519.8M | $791.8M | $429.7M | $564.8M | $318.8M | |
Short Term Investments | $86.2M | $180.2M | $328.8M | $103M | $94.1M | |
Accounts Receivable, Net | $108.1M | $149.5M | $184.2M | $108.8M | $121M | |
Inventory | $16.7M | $29.2M | $32M | $34.1M | $32.4M | |
Prepaid Expenses | $11.4M | $21.7M | $18.2M | $20.3M | $23.1M | |
Other Current Assets | $26M | $23.4M | $22.7M | $16.7M | $9.5M | |
Total Current Assets | $810.4M | $1.2B | $1.2B | $998.4M | $709.6M | |
Property Plant And Equipment | $414.9M | $548.7M | $697.3M | $891.6M | $857.4M | |
Long-Term Investments | $72.6M | $325M | $161.2M | $157.1M | $43.9M | |
Goodwill | $304.3M | $291.6M | $294.7M | $304.7M | $294.3M | |
Other Intangibles | $120.6M | $34.9M | $25.5M | $17.1M | $27.5M | |
Other Long-Term Assets | $1.1M | $985K | $4.1M | $926.3K | $3.6M | |
Total Assets | $1.8B | $2.5B | $2.4B | $2.5B | $2B | |
Accounts Payable | $52.3M | $82.2M | $104.3M | $148.5M | $89.3M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | $1.7M | $143.7M | -- | |
Current Portion Of Capital Lease Obligations | $18M | $16.4M | $15.9M | $21.1M | -- | |
Other Current Liabilities | $24.7M | $27.9M | $18.9M | $17M | $14.6M | |
Total Current Liabilities | $256.4M | $367.4M | $362.2M | $513.5M | $358.6M | |
Long-Term Debt | $407.1M | $369.5M | $352.1M | $527.4M | $408.7M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $907.6M | $970.9M | $1.1B | $1.3B | $998.9M | |
Common Stock | $201.6M | $200M | $189.8M | $195.9M | $184.8M | |
Other Common Equity Adj | -$46.2M | -$14.3M | -$40.1M | -$33.9M | -$7.6M | |
Common Equity | $891.1M | $1.6B | $1.3B | $1.2B | $991.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $891.1M | $1.6B | $1.3B | $1.2B | $991.2M | |
Total Liabilities and Equity | $1.8B | $2.5B | $2.4B | $2.5B | $2B | |
Cash and Short Terms | $605.9M | $972M | $758.5M | $667.8M | $412.9M | |
Total Debt | $426.1M | $410.4M | $353.7M | $692.2M | $461.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $470.8M | $737.2M | -- | $462.5M | $308.9M | |
Short Term Investments | $80.9M | $217.1M | -- | $97.7M | $101M | |
Accounts Receivable, Net | $135.4M | $104.7M | -- | $125.1M | $181.1M | |
Inventory | $17.9M | $29.1M | -- | $34.4M | $36.3M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $46.8M | $51.8M | -- | $66.6M | $63.7M | |
Total Current Assets | $797.6M | $1.2B | -- | $892.2M | $783.5M | |
Property Plant And Equipment | $439.5M | $581.9M | -- | $893M | $875.4M | |
Long-Term Investments | $126.9M | $264.1M | -- | $146.5M | $49.8M | |
Goodwill | $297.8M | $287.6M | -- | -- | -- | |
Other Intangibles | $112.2M | $32.5M | -- | -- | -- | |
Other Long-Term Assets | $1M | $964.3K | -- | $920.1K | $3.2M | |
Total Assets | $1.9B | $2.4B | -- | $2.4B | $2.1B | |
Accounts Payable | $64.3M | $83.4M | -- | $107.1M | $66.3M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | $17.9M | $40.3M | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $17.4M | $16.2M | -- | -- | -- | |
Other Current Liabilities | $19.8M | $29.4M | -- | $27.3M | $30.1M | |
Total Current Liabilities | $280.9M | $379.1M | -- | $478.4M | $386.3M | |
Long-Term Debt | $414.1M | $364M | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $923.4M | $976.8M | -- | $1.2B | $1.1B | |
Common Stock | $192.9M | $197.5M | -- | $191.7M | $192.4M | |
Other Common Equity Adj | -$26.3M | -$11.1M | -- | -$24.8M | -$20.2M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $929.7M | $1.5B | -- | $1.2B | $987.2M | |
Total Liabilities and Equity | $1.9B | $2.4B | -- | $2.4B | $2.1B | |
Cash and Short Terms | $551.7M | $954.3M | -- | $560.2M | $409.9M | |
Total Debt | $431.9M | $404.3M | -- | $677.7M | $65.9M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $7.2M | $255M | -$185.2M | -$90.8M | -$212.2M | |
Depreciation & Amoritzation | $64M | $83.3M | $87.7M | $100.7M | $110M | |
Stock-Based Compensation | $6M | $9.2M | $10.5M | $10.4M | $5.4M | |
Change in Accounts Receivable | -$20.6M | -- | -- | -- | -- | |
Change in Inventories | -$4.1M | -- | -- | -- | -- | |
Cash From Operations | $51.1M | $149.8M | $217M | $39.4M | $19.7M | |
Capital Expenditures | $113.1M | $140.7M | $191.3M | $233.8M | $143.1M | |
Cash Acquisitions | -$38.4M | -$33.7M | -$88.4M | -$21.8M | $46.3M | |
Cash From Investing | -$177.1M | -$287.3M | -$435.3M | -$14.4M | -$77M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $24.6M | $36.4M | -- | $238.1M | $974.1K | |
Long-Term Debt Repaid | -$30.5M | -$43.4M | -$56M | -$146.5M | -$165.6M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$4.1M | |
Cash From Financing | $281.4M | $465M | -$61.3M | $77.9M | -$174.7M | |
Beginning Cash (CF) | $316.4M | $500M | $737.5M | $449.5M | $553M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $155.4M | $327.5M | -$279.6M | $103M | -$232M | |
Ending Cash (CF) | $482.6M | $827.4M | $437.8M | $553.1M | $331.6M | |
Levered Free Cash Flow | -$62.1M | $9.1M | $25.8M | -$194.4M | -$123.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $63.5M | -$82.2M | -$14.9M | -$22.5M | -$33.2M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $3M | $71.4M | $672.4K | -$52.3M | -$33.5M | |
Capital Expenditures | $43.7M | $48.2M | $46.3M | $47M | $23M | |
Cash Acquisitions | -$10.5M | -$17M | -$3.5M | -$5.7M | -$5.6M | |
Cash From Investing | -$56M | -$107.4M | -$5M | -$33.6M | -$22.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $26.7M | -- | $1.4M | $1M | $46.3M | |
Long-Term Debt Repaid | -$5.9M | -$6.3M | -$4.7M | -$7.7M | -$8.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $1.1K | -- | $1.1K | |
Cash From Financing | $21.6M | -$5.9M | -$3.7M | -$6.4M | $37.3M | |
Beginning Cash (CF) | $509.2M | $784.7M | $445.9M | $554.9M | $322.4M | |
Foreign Exchange Rate Adjustment | $6.2M | -$1.6M | $5.7M | $2.6M | -$3.2M | |
Additions / Reductions | -$31.5M | -$42M | -$8.1M | -$92.3M | -$18.9M | |
Ending Cash (CF) | $483.9M | $741.1M | $443.5M | $465.2M | $300.3M | |
Levered Free Cash Flow | -$40.8M | $23.2M | -$45.6M | -$99.3M | -$56.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $51.8M | $109.3M | -$118M | -$98.4M | -$223M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $24.1M | $218.2M | $146.3M | -$13.6M | $38.6M | |
Capital Expenditures | $138.8M | $145.2M | $189.4M | $234.5M | $119.1M | |
Cash Acquisitions | -$43.5M | -$40.1M | -$74.9M | -$24M | $46.5M | |
Cash From Investing | -$218.2M | -$338.7M | -$332.9M | -$43M | -$66.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $51.2M | $9.8M | $1.4M | $237.7M | $46.2M | |
Long-Term Debt Repaid | -$32M | -$43.9M | -$54.4M | -$149.5M | -$166M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$4.1M | |
Cash From Financing | $307M | $437.5M | -$59.1M | $75.3M | -$131.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $112.8M | $317M | -$245.7M | $18.8M | -$158.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -$114.8M | $73.1M | -$43.1M | -$248.1M | -$80.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $63.5M | -$82.2M | -$14.9M | -$22.5M | -$33.2M | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $3M | $71.4M | $672.4K | -$52.3M | -$33.5M | |
Capital Expenditures | $43.7M | $48.2M | $46.3M | $47M | $23M | |
Cash Acquisitions | -$10.5M | -$17M | -$3.5M | -$5.7M | -$5.6M | |
Cash From Investing | -$56M | -$107.4M | -$5M | -$33.6M | -$22.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $26.7M | -- | $1.4M | $1M | $46.3M | |
Long-Term Debt Repaid | -$5.9M | -$6.3M | -$4.7M | -$7.7M | -$8.1M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | $1.1K | -- | $1.1K | |
Cash From Financing | $21.6M | -$5.9M | -$3.7M | -$6.4M | $37.3M | |
Beginning Cash (CF) | $509.2M | $784.7M | $445.9M | $554.9M | $322.4M | |
Foreign Exchange Rate Adjustment | $6.2M | -$1.6M | $5.7M | $2.6M | -$3.2M | |
Additions / Reductions | -$31.5M | -$42M | -$8.1M | -$92.3M | -$18.9M | |
Ending Cash (CF) | $483.9M | $741.1M | $443.5M | $465.2M | $300.3M | |
Levered Free Cash Flow | -$40.8M | $23.2M | -$45.6M | -$99.3M | -$56.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.